CA Skyrizi Cost & Savings
What Skyrizi (risankizumab) typically costs, why prices vary so much, and how to pay less for this autoimmune medication.
Unverified catalogue summary (cost-page product identity and category) for Skyrizi in CA; not checked against current local product information.
Why Skyrizi prices vary
There's no single price for Skyrizi. What you pay depends on your insurance plan and deductible, the pharmacy you use, your dosage, and whether you use a manufacturer copay card or a pharmacy discount card. Without insurance, brand-name autoimmune medications like Skyrizi from AbbVie Corporation can be costly, so it pays to compare your options before filling the prescription.
Unverified catalogue summary (manufacturer and therapeutic category) for Skyrizi in CA; not checked against current local product information.
Is there a generic or biosimilar?
Approval year does not show whether an approved generic or biosimilar is currently available. Check the FDA Orange Book for drugs or Purple Book for biologics, then ask a pharmacist whether an alternative is available and appropriate for your prescription.
FDA resources: Orange Book and Purple Book.
Compare costs of similar autoimmune drugs
Unverified catalogue summary (category and related-medication grouping) for Skyrizi in CA; not checked against current local product information.
Savings options for other heavily advertised autoimmune medications.
Humira cost & savings
adalimumab
Unverified catalogue summary (related drug identity) for Humira in CA; not checked against current local product information.
Dupixent cost & savings
dupilumab
Unverified catalogue summary (related drug identity) for Dupixent in CA; not checked against current local product information.
Rinvoq cost & savings
upadacitinib
Unverified catalogue summary (related drug identity) for Rinvoq in CA; not checked against current local product information.
Sources and editorial standards
Product-label references, not clinical verification. Medicine identification—not prescribing guidance. This page does not provide a complete safety or dosing reference. Check the official label for your country and exact product, and consult your pharmacist or prescriber before starting, stopping or changing treatment. Missing information does not mean a medicine is safe for you. Reference formulation scope (not dosing instructions): Risankizumab SC sterile solution: 150 mg/1 mL, 180 mg/1.2 mL, 360 mg/2.4 mL and 90 mg/1 mL; IV concentrate 600 mg/10 mL for infusion. Crohn's/UC treatment includes IV induction and SC maintenance.
Unresolved / not established by these sources:
- Clinical summaries, safety tiers and dosing guidance are withheld while their review remains unfinished.
- A linked document may have been superseded. Confirm country, product, formulation and latest revision with the regulator or pharmacist.
- CA label reference: Skyrizi — Canadian prescribing monograph (authorized 2026-07-08)
Manufacturer label · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
- CA regulator product record (not a prescribing label): Health Canada — Summary Basis of Decision
Local licence · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
Lookup resources (not product-specific citations; confirm formulation and country before use):
Frequently asked questions
How much does Skyrizi cost?
Unverified catalogue product facts, including manufacturer and therapeutic category; pricing guidance is general and not a quoted product price. The list price of Skyrizi (risankizumab) varies widely depending on your insurance, pharmacy and dosage. Brand-name autoimmune drugs are often expensive without coverage, which is why most people use insurance, manufacturer copay cards or pharmacy discount cards to lower the price.
Is there a generic or biosimilar version of Skyrizi?
Unverified catalogue product facts, including manufacturer and therapeutic category; pricing guidance is general and not a quoted product price. Approval age alone does not establish whether a generic or biosimilar version of Skyrizi is currently available. Check the FDA Orange Book for drugs or Purple Book for biologics, then ask a pharmacist whether an alternative is available and appropriate for you.
How can I save money on Skyrizi?
Unverified catalogue product facts, including manufacturer and therapeutic category; pricing guidance is general and not a quoted product price. Common ways to lower the cost include checking your insurance formulary, asking AbbVie Corporation about a manufacturer copay or patient-assistance program, and comparing prices with a free pharmacy discount card such as GoodRx or SingleCare.